홈 › 만성 폐쇄성 폐질환 › 앨라배마
앨라배마의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 22개가 앨라배마 내 여러 지역에서 참여자를 모집하고 있습니다.
앨라배마의 도시
공식 연구 텍스트(영어)
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
피험자 모집 중2상
40세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
피험자 모집 중4상
40세 ~ 85세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
피험자 모집 중관찰 연구
50세 ~ 99세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
피험자 모집 중3상
40세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
피험자 모집 중
22세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
피험자 모집 중관찰 연구건강한 지원자 환영
30세 ~ 55세 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05033990Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
- University of Alabama at Birmingham, Birmingham
피험자 모집 중2상
40세 ~ 80세 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT05270525Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
피험자 모집 중
40세 ~ 80세 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
피험자 모집 중
40세 ~ 84세 · 모든 성별 · 2026. 4. 24. 업데이트됨 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 1. 16. 업데이트됨 · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
피험자 모집 중4상
19세 이상 · 모든 성별 · 2025. 11. 10. 업데이트됨 · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
피험자 모집 중
30세 이상 · 모든 성별 · 2025. 2. 6. 업데이트됨 · NCT05204888ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.